Quantifying Cardiovascular Risks in Patients With Metabolic Syndrome Undergoing Total Joint Arthroplasty

Journal of Arthroplasty

Volumn 27, Issue 4, 2012, Pages 514-519

  Gandhi, Kishor ^a   Viscusi, Eugene R ^a   Schwenk, Eric S ^a   Pulido, Luis ^b   Parvizi, Javad ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Cardiovascular complications; Joint arthroplasty; Metabolic abnormalities; Metabolic syndrome; Risk profile

Indexed keywords

ADULT; ARTICLE; BODY MASS; BRADYCARDIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; RISK FACTOR; TOTAL KNEE REPLACEMENT;

AGED; ARRHYTHMIAS, CARDIAC; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84858278993     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.06.027     Document Type: Article

References (21)

1. Reaven G.M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988, 37:1595.
2. Alberti K.G., Zimmet P.Z. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539.
3. National Institutes of Health Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): executive summary 2001, National Institutes of Health, Bethesda, [Publication No. 01-3670].
4. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356.
5. Kolovou G.D., Anagnostopoulou K.K., Salpea K.D., et al. The prevalence of metabolic syndrome in various populations. P Am J Med Sci 2007, 333:362.
6. Haffner S.M., Stern M.P., Hazuda H.P., et al. Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes 1986, 10:493.
7. Bagry H.S., Sreekrishna R., Carli F. Metabolic syndrome and insulin resistance: preoperative considerations. Anesthesiology 2008, 108:506.
8. Alexander C.M., Landsman P., Teutsch S.M., et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210.
9. Anuurad E., Chiem A., Pearson T.A., et al. Metabolic syndrome components in African-Americans and European-American patients and its relation to coronary artery disease. J Am Cardiol 2007, 100:830.
10. Mancia G., Bombelli M., Corrao G., et al. The metabolic syndrome in the PAMELA population: daily life blood pressure, cardiac damage and prognosis. Hypertension 2007, 49:40.
11. Levin P.D., Weissman C. Obesity, metabolic syndrome, and the surgical patient. Med Clin N America 2009, 93:1049.
12. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and All causes in United States adults. Circulation 2004, 110:1245.
13. Kahn R., Buse J., Ferrannini E., et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289.
14. Echahidi N., Pibarot P., Despres J.P., et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 2007, 50:843.
15. Kurtz S., Ong K., Lau E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89:780.
16. O'Reilly R.F., Burgess I.A., Zicat B. The prevalence of venous thromboembolism after hip and knee replacement surgery. Med J of Australia 2005, 182:154.
17. Gandhi R., Razak F., Tso P., et al. Metabolic syndrome and the incidence of symptomatic deep vein thrombosis following total knee arthroplasty. J Rheumatol 2009, 36:2298.
18. Phillip C.B., Barrett J.A., Losina E., et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am 2003, 85A:21.
19. Parvizi J., Mui A., Purtill J.J., et al. Total joint arthroplasty: when do fatal or near-fatal complications occur?. J Bone Joint Surg Am 2007, 89A:27.
20. Mahomed N.N., Barrett J.A., Katz J.N., et al. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am 2003, 85A:27.
21. Engstrom G., De Verdier M.G., Rollof J., et al. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage 2009, 17:168.